DAFNA Capital Management »

Tandem Diabetes Care shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Tandem Diabetes Care (TNDM) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Tandem Diabetes Care

Tip: Access up to 7 years of quarterly data

All positions including Tandem Diabetes Care held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tandem Diabetes Care by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.5M 221k 29.58
2023-09-30 $4.6M 221k 20.77
2023-06-30 $2.7M 110k 24.54
2018-03-31 $298k 60k 4.97

More positions owned by DAFNA Capital Management

Spdr S&p Biotech Etf Etf (XBI)
Cytokinetics Com New (CYTK)
Stereotaxis Com New (STXS)
Ideaya Biosciences (IDYA)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Karuna Therapeutics Ord
Revolution Medicines (RVMD)
Ishares Nasdaq Biotech Indx Etf (IBB)
Xenon Pharmaceuticals (XENE)
Merus N V (MRUS)
Blueprint Medicines (BPMC)
Day One Biopharmaceuticals I (DAWN)
Neurocrine Biosciences (NBIX)
Dex (DXCM)

View all positions for DAFNA Capital Management

Top funds holding Tandem Diabetes Care

Vanguard Group
Arrowpoint Asset Management
Henderson Group
Bellevue Group
Jacobs Levy Equity Management
Jennison Associates
Jennifer Ranahan
Paradice Investment Management
Two Sigma Advisers
Point72 Asset Management
Voloridge Investment Management
Two Sigma Investments
Chicago Capital
Millennium Management
Squarepoint Ops

View all funds holding Tandem Diabetes Care